Simon Newman

Current Organisation: NANOGENICS LIMITED
(some projects in the list below may not be associated with this organisation)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£346,253

Nov 19 - Jan 21

Development of a breakthrough anti-fibrotic gene therapy to improve surgical outcomes and reduce re-admission rates for patients with severe glaucoma.

Innovate UK award to NANOGENICS LIMITED and Simon Newman

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}